Clapping at seminar
Inside:
Events

Drug diversion prevention and detection: using a comprehensive risk and internal audit approach

Join us for breakfast and an interactive discussion on drug diversion, followed by networking.

Drug diversion is a national crisis affecting public health and social and economic welfare. Drug diversion activities not only cause potential harm to patients and healthcare professionals, but also to the organizations that employ them – causing healthcare organizations to face legal, financial, operational and reputational risks and regulatory fines. Now consider that about 15% of all healthcare workers will misuse drugs or alcohol at some point in their career.  To effectively address these issues and mitigate risks, healthcare organizations must have a comprehensive interdisciplinary drug diversion management program that includes rigorous controls, routine audits and monitoring.

Agenda
8 – 8:30 a.m. – Registration and breakfast
8:30 – 10 a.m. – Education session
10 – 10:30 a.m. – Q&A and networking

Learning objectives

  • Identify the impact of drug diversion on patients and healthcare organizations
  • Explain the common points of risks and methods of drug diversion in healthcare’s controlled substance life cycle
  • Describe the best practices for drug diversion prevention and detection
  • Understand best practices of an employer drug testing program

Who should attend
Chief executive officers, chief financial officers, chief compliance officers, chief human resources (HR) officers, chief audit executives, chief risk officers, chief nursing officers, vice presidents/directors of finance, vice presidents/directors of HR, vice presidents/directors of compliance and other management professionals of acute care healthcare providers, academic medical centers and other healthcare provider organizations

Presenters

Janice Ahlstrom, FHIMSS, CPHIMS, CCSFP, RN, BSN
Director, Baker Tilly

Deb Bowes, CPA, CHFP
Partner, Baker Tilly

Kim Wylam, SPHR
President and Managing Partner, Baker Tilly Vantagen

Information about CPE eligibility

There are no prerequisites for this event, and advance preparation is not required. There is no cost to attend this event.

Level: basic
CPE credit:
one and a half (1.5) hour total credit
Field of study: Auditing

A certificate of completion will be emailed to you four to six weeks following the event.

For more information regarding administrative policies such as complaint and refund policies, please contact Heather Eggers at +1 (608) 240 2522.

Baker Tilly Virchow Krause, LLP is registered with the National Association of State Boards of Accountancy (NASBA) as a sponsor of continuing professional education on the National Registry of CPE Sponsors. State boards of accountancy have final authority on the acceptance of individual courses for CPE credit. Complaints regarding registered sponsors may be submitted to the National Registry of CPE Sponsors through its website: learningmarket.org.

Similar events